ICP
NVO

Interchange Capital Partners’s Novo Nordisk NVO Stock Holding History

Interchange Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,942
Closed -$231K – 292
2024
Q3 		$231K Sell
1,942
-25
-1% -$3.33K 0.08% 236
2024
Q2 		$281K Buy
+1,967
New +$261K 0.1% 198
2021
Q1 		– Sell
-796
Closed -$27K – 813
2020
Q4 		$27K Buy
+796
New +$27.5K 0.01% 545

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Interchange Capital Partners's NVO Position: Q4 2024 in Review

Interchange Capital Partners sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,942 shares — an estimated $231K sold.

Interchange Capital Partners first reported a position in NVO in Q4 2020 and held it in 3 quarters. The position peaked at $281K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Interchange Capital Partners reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Interchange Capital Partners sold 1,942 Novo Nordisk shares in Q4 2024, an estimated $231K.
  • Interchange Capital Partners first reported a position in Novo Nordisk in Q4 2020 and held it in 3 quarters.
  • Interchange Capital Partners's Novo Nordisk position peaked at $281K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Interchange Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.